Senior Director, Clinical Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

Annexon Biosciences · 2 days ago

Senior Director, Clinical Development

Annexon Biosciences is a biopharmaceutical company focused on developing therapies for neuroinflammatory diseases. The Sr. Director of Clinical Development will lead clinical strategy and execution for development programs, ensuring scientific integrity and regulatory compliance while collaborating with cross-functional teams.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics

Responsibilities

Lead the strategic direction and execution of clinical development programs, from early-phase through late-stage clinical trials ensuring they are scientifically robust and meet regulatory requirement
Collaborate cross-functionally with teams in clinical operations, regulatory affairs, medical affairs, pharmacovigilance, and biostatistics to ensure the successful execution of clinical development plans
Drive the preparation, submission, and management of regulatory filings, including clinical trial applications, investigator brochures, and study protocols, ensuring alignment with global regulatory guidelines (FDA, EMA)
Analyze, interpret, and communicate clinical trial data to inform key decisions, providing clear recommendations to guide clinical development strategy
Establish and maintain strategic relationships with key opinion leaders (KOLs), clinical investigators, and external stakeholders to advance clinical initiatives
Manage clinical trial budgets, timelines, and resources, ensuring the delivery of high-quality results aligned with corporate objectives
Regularly present clinical progress, data outcomes, and strategic recommendations to executive leadership, stakeholders, and external partners
Stay at the forefront of industry trends, scientific advancements, and regulatory developments to ensure the company remains competitive in the clinical development strategies
Identify potential risks in clinical development timelines, budgets, or regulatory pathways, and develop contingency plans to mitigate them

Qualification

Clinical trial designRegulatory complianceLeadership in clinical developmentCNS-related experienceAnalytical skillsStrategic thinkingCommunication skillsProblem-solving skillsCollaboration skills

Required

MD or PhD in Neurology, Neuroscience, or a related field
Over 10 years of experience in clinical development, with a focus on CNS-related indications
Proven leadership in designing, managing, and executing clinical trials from early phase through late-stage development
Demonstrated experience in leading clinical development teams at a senior or executive level, ideally within a high-growth biotech or pharmaceutical environment
In-depth knowledge of global regulatory requirements and guidelines (e.g., FDA, EMA) and clinical development processes, including Experience in HA meetings, writing briefing books, attending/supporting meetings
Exceptional leadership, strategic thinking, and communication skills with a proven ability to influence across functions and levels
Ability to work effectively in a fast-paced, dynamic environment and manage multiple priorities
Strong analytical and problem-solving skills, with a data driven approach to decision making
Demonstrated success in building collaborations with cross-functional teams and external partners in a dynamic, fast paced environment

Preferred

Experience with regulatory submissions and clinical trial oversight in a biotech or pharmaceutical setting
Familiarity with emerging trends in neurology, including cutting-edge therapeutic modalities

Benefits

Flexible work schedules
Remote opportunities
The ability to achieve a work-life balance
Shuttle service from BART, CalTrain and the Ferry
Equity participation
Employee stock purchase plan
A comprehensive health benefit package that includes medical, dental, vision, 401(k), flexible spending plans, and other benefits

Company

Annexon Biosciences

twittertwittertwitter
company-logo
Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Funding

Current Stage
Public Company
Total Funding
$720.25M
Key Investors
Redmile GroupBain Capital Life SciencesNew Enterprise Associates
2025-11-12Post Ipo Equity· $86.25M
2024-06-05Post Ipo Equity· $125M
2023-12-20Post Ipo Equity· $125M

Leadership Team

leader-logo
Douglas Love
President & CEO
linkedin
L
Lloyd Clark
Senior Vice President, Ophthalmology Strategy and Innovation
linkedin
Company data provided by crunchbase